News from relmada therapeutics inc

Jul 09, 2014, 07:30 ET

Camp Nine Inc. Announces Corporate Name Change To Relmada Therapeutics Inc.

 Camp Nine, Inc., (OTCBB: CMPE), a Nevada corporation which conducts its operations through Relmada Therapeutics, Inc., a clinical-stage...

Jul 01, 2014, 07:45 ET

Relmada Therapeutics Files Shares Registration Statement

 Camp Nine, Inc. (the "Company"), which conducts its operations through Relmada Therapeutics, Inc. ("Relmada") (OTCBB: CMPE), a clinical-stage...

Jun 19, 2014, 07:30 ET

Relmada Therapeutics to Present at the 2014 BIO International Convention

 Relmada Therapeutics, which currently conducts its operations through Camp Nine, Inc. (the "Company"), (OTCBB: CMPE), a clinical-stage company...

Jun 16, 2014, 07:30 ET

Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million In Connection With Going Public Transaction

 Camp Nine, Inc. (the "Company"), which conducts its operations through Relmada Therapeutics Inc. ("Relmada") (OTCBB: CMPE), a clinical-stage...

Dec 11, 2013, 07:00 ET

Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer

 Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that Douglas...

Oct 01, 2013, 07:00 ET

Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise In Series A Financing

 Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced the final...

Sep 16, 2013, 07:00 ET

Relmada Therapeutics Announces Collaboration With The Malvern Consulting Group

 Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that has...

Sep 10, 2013, 07:00 ET

Relmada Therapeutics Announces Positive Results of LevoCap ER Pivotal Pharmacokinetic Study

Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive...

May 20, 2013, 07:00 ET

Relmada Therapeutics Gears Up To Become A Publicly Traded Company

 Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that has...

Mar 04, 2013, 13:00 ET

Relmada Therapeutics Announces LevoCap ER Development Progress

 Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced the...

Jan 04, 2013, 07:00 ET

Relmada Therapeutics To Present At The Biotech Showcase™ 2013

Relmada Therapeutics, a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that Sergio Traversa,...

Jul 24, 2012, 07:00 ET

Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing

 Relmada Therapeutics, a clinical-stage company developing novel therapies for the treatment of chronic pain today announced the initial...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge